1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited

SMSPHARMA.NS
SMS Pharmaceuticals LimitedIN flagNational Stock Exchange of India
420.40
INR
-1.05
- -
39.37BMarket Cap

Total Valuation

SMS Pharmaceuticals Limited carries a market capitalization of 39.37B, placing it among publicly traded companies globally. Its enterprise value stands at 36.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap39.37B
Enterprise Value36.88B

Share Statistics

SMS Pharmaceuticals Limited currently has 93.65M shares outstanding.

Shares Outstanding93.65M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

SMS Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 33.06. The price-to-sales ratio is 3.80, and the price-to-book ratio stands at 360.07.

PE Ratio33.06
PS Ratio3.80
PB Ratio360.07
P/TBV Ratio4.31
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, SMS Pharmaceuticals Limited trades at an EV/EBITDA multiple of 28.07 and an EV/FCF ratio of 211.82. The EV/Sales ratio of 4.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.07 provides insight into valuation relative to core operating earnings.

EV / Sales4.16
EV / EBITDA28.07
EV / EBIT28.07
EV / FCF211.82

Financial Position

SMS Pharmaceuticals Limited maintains a current ratio of 1.81, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.46, indicating elevated leverage, while an interest coverage ratio of 5.69 demonstrates adequate ability to service its debt obligations.

Current Ratio1.81
Quick Ratio0.14
Debt / Equity46.46
Debt / EBITDA2.78
Interest Coverage5.69

Financial Efficiency

SMS Pharmaceuticals Limited posts a return on equity of 51.21 and a return on invested capital of 9.43.

Return on Equity (ROE)51.21
Return on Assets (ROA)8.11
Return on Invested Capital (ROIC)9.43
Return on Capital Employed (ROCE)22.23
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.85

Taxes

Over the trailing twelve months, SMS Pharmaceuticals Limited has paid 286.40M in income taxes, reflecting an effective tax rate of 24.55.

Income Tax286.40M
Effective Tax Rate24.55

Stock Price Statistics

SMS Pharmaceuticals Limited's stock has gained approximately 73.39658% over the past 52 weeks. The 50-day moving average sits at 389.99, while the 200-day moving average is 346.05.

Beta (5Y)N/A
52-Week Price Change73.39658%
50-Day Moving Average389.99
200-Day Moving Average346.05
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, SMS Pharmaceuticals Limited generated 8.87B in revenue and converted that into 1.02B in net income, yielding earnings per share of 11.34. EBITDA reached 1.31B, while operating income came in at 1.31B.

Revenue8.87B
Gross Profit2.98B
Operating Income1.31B
Pretax Income1.17B
Net Income1.02B
EBITDA1.31B
EBIT1.31B
Earnings Per Share (EPS)11.34

Balance Sheet

SMS Pharmaceuticals Limited holds 495.23M in cash and equivalents against 3.65B in total debt, resulting in a net debt position of 3.19B. Total book value stands at 93.65M, with working capital of 2.85B providing operational flexibility.

Cash & Cash Equivalents495.23M
Total Debt3.65B
Net Debt3.19B
Equity (Book Value)93.65M
Book Value Per Share1.04
Working Capital2.85B

Margins

SMS Pharmaceuticals Limited operates with a gross margin of 33.64, reflecting its pricing power and cost economics. The operating margin of 14.81 and net profit margin of 11.50 provide insight into operational efficiency.

Gross Margin33.64
Operating Margin14.81
Pretax Margin13.15
Profit Margin11.50
EBITDA Margin14.81

Stock Splits

SMS Pharmaceuticals Limited's most recent stock split took place on December 17, 2015 with a 1:10 split ratio.

Last Split Date12/17/2015
Split Ratio1:10

Scores

SMS Pharmaceuticals Limited posts an Altman Z-Score of 4.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.73